Support our Foundation of Myology project
MIS51ON
A randomised, double-blind, dose-finding and dose-comparison study of eteplirsen in DMD, evaluating the safety and efficacy of high-dose eteplirsen in patients with DMD with deletion mutations amenable to exon 51 skipping.